FDA calls for new regulations for drug compounders

The New York Times reports that the commissioner of the Food and Drug Administration on called on Congress to empower the agency to better police compounding pharmacies like the one at the center of a national meningitis outbreak. But Republican lawmakers pushed back, arguing that the agency has enough authority, leaving it unclear whether the House would support efforts to increase oversight.  The Times had previously disclosed that despite two decades of dire health warnings, the industry has until now fought off tougher federal oversight with the help of powerful allies in Congress.